|
|
|
|
|
by ef4
3916 days ago
|
|
Because the red tape is fairly extreme. For proof, look at the prices a company like this will pay to "buy up" a generic drug. You'd think it wouldn't really be possible to sell rights to a generic drug for millions of dollars, but apparently you'd be wrong. I guarantee there are manufacturers in the world who would be happy to have the business and could rapidly drive the price down to competitive generic levels again. But they are locked out by the bureaucracy. |
|